Literature DB >> 27023843

[Intercultural adaptation of the AIMS in German language: A scale for abnormal involuntary movements].

C Buhmann1, A Rizos2, D Emmans3, W H Jost3.   

Abstract

BACKGROUND: Dyskinesias are abnormal involuntary movements and occur across many movement disorders. In Parkinson's disease dyskinesias can be troublesome and are a determinant of the quality of life throughout the course of the disease. Assessment and rating of dyskinesias is thus important for clinical assessment of patients, as well as for academic studies and clinical trials. The abnormal involuntary movement scale (AIMS) is an English language standardised, reliable and validated scale to evaluate dyskinesias. In this article we present a linguistically validated German version of AIMS.
METHODS: The intercultural adaptation of the German translation was performed following an internationally accepted procedure. Firstly, two neurologists independently translated the original into German. Taking both versions into account, a consensus version was agreed on by both translators and was tested on 10 patients. This preliminary German version was then independently translated back into the original language by two different neurologists, and again, a consensus version was agreed on. All translators then compared this English version to the original. Subsequently, the German version was linguistically modified until it resulted in a final German version, which was agreed on by all translators, deemed linguistically acceptable, and the translation back into English was considered to be as unambiguous as possible. This final German version of AIMS was applied to 50 patients in two different hospitals for diagnostic purposes and tested for feasibility and comprehension.
RESULTS: In this paper, we present an intercultural adaptation of a linguistically validated German version of AIMS.

Entities:  

Keywords:  AIMS; Dyskinesia; Parkinson’s disease; Translation; Validation

Mesh:

Year:  2016        PMID: 27023843     DOI: 10.1007/s00115-016-0099-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  16 in total

Review 1.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

2.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

3.  Unawareness of dyskinesias in Parkinson's and Huntington's diseases.

Authors:  C Vitale; M T Pellecchia; D Grossi; N Fragassi; T Cuomo; L Di Maio; P Barone
Journal:  Neurol Sci       Date:  2001-02       Impact factor: 3.307

4.  Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.

Authors:  G D Tollefson; C M Beasley; R N Tamura; P V Tran; J H Potvin
Journal:  Am J Psychiatry       Date:  1997-09       Impact factor: 18.112

5.  A rating scale for tardive dyskinesia.

Authors:  G M Simpson; J H Lee; B Zoubok; G Gardos
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

6.  Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.

Authors:  Christopher G Goetz; Philippe Damier; Christine Hicking; Eugene Laska; Thomas Müller; C Warren Olanow; Olivier Rascol; Hermann Russ
Journal:  Mov Disord       Date:  2007-01-15       Impact factor: 10.338

7.  Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

Authors:  C G Goetz; G T Stebbins; H M Shale; A E Lang; D A Chernik; T A Chmura; J E Ahlskog; E E Dorflinger
Journal:  Mov Disord       Date:  1994-07       Impact factor: 10.338

8.  Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale.

Authors:  J M Rey; G E Hunt; G F Johnson
Journal:  Aust N Z J Psychiatry       Date:  1981-03       Impact factor: 5.744

Review 9.  Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.

Authors:  Carlo Colosimo; Pablo Martínez-Martín; Giovanni Fabbrini; Robert A Hauser; Marcelo Merello; Janis Miyasaki; Werner Poewe; Cristina Sampaio; Olivier Rascol; Glenn T Stebbins; Anette Schrag; Christopher G Goetz
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

10.  Tardive dyskinesia prevalence rates during a ten-year follow-up.

Authors:  C H Miller; I Simioni; H Oberbauer; J Schwitzer; C Barnas; F Kulhanek; K E Boissel; U Meise; H Hinterhuber; W W Fleischhacker
Journal:  J Nerv Ment Dis       Date:  1995-06       Impact factor: 2.254

View more
  1 in total

1.  The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care.

Authors:  Odette Fründt; Tina Mainka; Beate Schönwald; Bianca Müller; Polina Dicusar; Christian Gerloff; Carsten Buhmann
Journal:  J Neural Transm (Vienna)       Date:  2018-08-22       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.